JLK,Inc. Stock

Equities

A322510

KR7322510009

Software

End-of-day quote Korea S.E. 06:00:00 2024-06-06 pm EDT 5-day change 1st Jan Change
15,810 KRW -6.00% Intraday chart for JLK,Inc. +0.70% -27.97%
Sales 2022 3.42B 2.48M Sales 2023 2.49B 1.8M Capitalization 348B 252M
Net income 2022 -9.01B -6.53M Net income 2023 -7.32B -5.31M EV / Sales 2022 16.3 x
Net Debt 2022 8.31B 6.02M Net Debt 2023 11.95B 8.66M EV / Sales 2023 144 x
P/E ratio 2022
-5.21 x
P/E ratio 2023
-46.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 74.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day-6.00%
1 week+0.70%
Current month+0.70%
1 month+23.61%
3 months+24.68%
6 months-30.04%
Current year-27.97%
More quotes
1 week
15 340.00
Extreme 15340
17 310.00
1 month
12 450.00
Extreme 12450
17 310.00
Current year
8 990.00
Extreme 8990
24 900.00
1 year
8 990.00
Extreme 8990
39 050.00
3 years
3 100.00
Extreme 3100
39 050.00
5 years
3 100.00
Extreme 3100
39 050.00
10 years
3 100.00
Extreme 3100
39 050.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 -
Founder 59 14-02-17
Members of the board TitleAgeSince
Founder 59 14-02-17
Chief Executive Officer 47 -
More insiders
Date Price Change Volume
24-06-07 15,810 -6.00% 506,205
24-06-05 16,820 +0.90% 698,366
24-06-04 16,670 +4.45% 734,494
24-06-03 15,960 +1.66% 592,782
24-05-31 15,700 -4.21% 1,103,799

End-of-day quote Korea S.E., June 06, 2024

More quotes
JLK Inc, formerly JLK Inspection Inc, is a Korea-based company principally engaged in the development of artificial intelligence (AI) software. The Company develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.
More about the company
  1. Stock Market
  2. Equities
  3. A322510 Stock